FACTBOX - Five facts on German billionaire Adolf Merckle

Tue Jan 6, 2009 6:55pm GMT
 
Email | Print | | Single Page
[-] Text [+]

(Reuters) - German billionaire Adolf Merckle, whose family controls HeidelbergCement and generic drug company Ratiopharm, has committed suicide, his family said on Tuesday.

Here are five facts on Adolf Merckle:

* Merckle suffered big losses last year and came under pressure to sell some assets or seek bridging loans after sellers of shares in carmaker Volkswagen AG were caught short by a stakebuilding announcement from VW's biggest shareholder Porsche that sent the VW share price rocketing.

* The father of four was the world's 94th-richest person in 2008, according to Forbes magazine, and had assembled a business conglomerate with about 100,000 employees and 30 billion euros (27.3 billion pounds) in annual sales.

* Merckle's fortune was based on an inheritance from his Bohemian grandfather but he grew the chemical wholesale company into Germany's largest drugs wholesaler, Phoenix Pharmahandel, with annual sales of 21.6 billion euros, according to Forbes.

* The Merckle family's vast portfolio of business interests also includes generic drugs maker Ratiopharm and a majority stake in HeidelbergCement as well as stakes in a maker of grooming vehicles for ski slopes, a sugar refinery and one of Germany's oldest foundries.

* Media-shy Merckle, who died at the age of 74 and was a lawyer by education, lived in the southwest German state of Baden-Wuerttemberg and was said to enjoy skiing and mountain climbing.

(Editing by Greg Mahlich)

 
A dealer works on the trading floor shortly after the U.S. markets opened, at CMC Markets in London October 3, 2008. REUTERS/Toby Melville
Hormones make best traders

Scientists say a perfect combination of testosterone, experience and a hunger for a share of profits can produce financial traders who consistently outperform.  Full Article | Related Story 

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives

Most Popular Business News on Reuters UK

  • Articles
  • Videos